Background-Elevated blood pressure is the leading modifiable risk factor for cardiovascular
Blood pressure is a major risk factor for cardiovascular disease (CVD) that accounts for almost 8 million premature deaths per year worldwide. 1, 2 Over the past decades, medications used to treat hypertension and prevent CVD events were designed to reduce mean arterial pressure (MAP).
However, this MAP-focused approach may be suboptimal in light of the preponderance of predominant or isolated systolic hypertension, particularly among patients with persistently elevated blood pressure despite treatment. [3] [4] [5] To assess residual CVD risk associated with persistently elevated blood pressure, investigators have evaluated novel measures of aortic stiffness and hemodynamic load, such as peripheral and central pulse pressure (PP) and aortic pulse wave velocity, which may be predictive of CVD progression and events. [6] [7] [8] [9] [10] [11] [12] [13] [14] Indeed, we have shown previously that increased carotid-femoral pulse wave velocity (CFPWV) is associated with increased risk for CVD events. 6 Yet, little is known about the relative and incremental contributions to CVD risk of the mean and various pulsatile components of blood pressure.
PP plays an important role in the pathogenesis of hypertension, particularly after midlife, and higher PP is related to clinical events. 11, [15] [16] [17] [18] However, the components of PP that confer higher risk remain unclear. Some have argued that greater wave reflection, as indicated by augmentation index or augmented pressure, is associated with increased risk. 7, [19] [20] [21] Yet, augmentation index and augmented pressure are composite measures that may be affected by forward and backward waves. 22, 23 One must measure pressure and flow in order to separate forward and backward waves and compute the global reflection coefficient, which is the reference standard for assessing wave reflection. 24, 25 Systolic blood pressure (SBP) has been proposed as a primary guide to prognosis and therapy; however, SBP provides an aggregate measure of the effects of mean and pulsatile pressure that may potentially overlook components have shown previously that increased carotid-femoral pulse wave velocity (CFPW PW WV) V) V i is s s associated with increased risk for CVD events. 6 Yet, little is known about the relative and of each. Therefore, knowledge of SBP alone does not establish whether an individual has an abnormality of mean or pulsatile load, which is a distinction that may have treatment implications. Moreover, an earlier Framingham study showed that blood pressure models combining SBP with diastolic blood pressure (DBP) or PP with MAP were superior to any of the four single blood pressure components (SBP, DBP, MAP or PP) considered alone at predicting CVD risk. 26 To our knowledge, no prior community-based study has compared the relations to incident CVD of a comprehensive panel of individual mean and pulsatile components of blood pressure derived from an analysis of measured central aortic pressure and flow. We hypothesized that true central forward pressure wave amplitude (FWA), the primary hemodynamic correlate of variability in central and peripheral PP in younger and older individuals, 27 would be an important predictor of CVD risk in models that adjusted for standard risk factors, including SBP.
Methods

Participants
The design and selection criteria for the Framingham Offspring study have been detailed previously. 28 Participants attending the eighth examination cycle of the Offspring cohort (N=3021; [2005] [2006] [2007] [2008] were eligible for this analysis. Tonometry measurements were first implemented beginning in February 1999 as described previously. 29 A more comprehensive assessment of proximal aortic pressure-flow relations was implemented beginning with examination cycle eight of the Offspring cohort. Participants were excluded for the following reasons: prior CVD (n=295); off-site exam with no laboratory data (n=79); incomplete hemodynamic data (n=110); no follow up after examination cycle (n=12); missing covariate data (n=33). Only 45 (1.5%) participants were missing data on covariates or follow up. All protocols hat true central forward pressure wave amplitude (FWA), the primary hemodyn nam am amic ic i c cor r orre re rela la late te of variability in central and peripheral PP in younger and older individuals, 27 would be an importan pr red ed dic ic icto to tor r of of of C C CVD D D r r ris i k in models that adjusted for or or st tandard risk fac ac ctors rs, , in in including SBP. d
were approved by Boston University Medical Center's Institutional Review Board and participants provided written informed consent.
Clinical Evaluation and Definitions
Medical history, physical examination, and electrocardiography were performed routinely at each Framingham Heart Study (FHS) examination. 28 Physician-acquired blood pressures represent the mean of two auscultatory measurements obtained on seated participants at the time of the Framingham clinic examination. The physician blood pressures were acquired using a mercury column sphygmomanometer and a standardized protocol with excellent measurement reproducibility. Peripheral PP was calculated as the difference between SBP and DBP. Body mass index was calculated by dividing weight in kilograms by the square of the height in meters.
Criteria for diabetes mellitus were a fasting glucose level of 126 mg/dL (7.0 mmol/L) or greater, or the use of medications to treat diabetes. Smoking was defined as regular use of cigarettes in the prior year.
Non-invasive hemodynamics
Hemodynamic data were acquired as previously described. 6 Participants were studied in the supine position after a 5-minute rest. Supine auscultatory brachial SBP and DBP at the time of tonometry (referred to as tonometry blood pressures) were obtained using a computer-controlled device. Arterial tonometry with simultaneous electrocardiography was obtained from brachial, radial, femoral, and carotid arteries using a custom tonometer. Next, 2-dimensional echocardiographic images of the left ventricular outflow tract were obtained from a parasternal long axis view followed by pulsed Doppler of the left ventricular outflow tract from an apical 5-chamber view. Tonometric, electrocardiographic, and echocardiographic data were digitized during the primary acquisition and transferred to the core laboratory (Cardiovascular mass index was calculated by dividing weight in kilograms by the square of the h he heig ig gh ht t i i in n n me me mete ters.
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Tonometry waveforms were signal-averaged using the electrocardiographic R-wave as a fiducial point. 6 Cuff SBP and DBP obtained at the time of tonometry were used to calibrate the peak and trough of the signal-averaged brachial pressure waveform. DBP and integrated brachial MAP were used to calibrate carotid pressure tracings. 30 Calibrated carotid pressure was used as a surrogate for central pressure. 30 MAP was calculated by integration of the calibrated brachial pressure waveform. By using measured central pressure and flow, the forward and backward pressure waves were separated as described previously (Figure 1 ). 6 The FWA was defined as the difference between pressure at the foot and at the peak of the forward pressure waveform. The global reflection coefficient was calculated as backward wave amplitude divided by FWA. The primary pressure wave amplitude, a pressure-only surrogate for FWA, was defined as the pressure difference between the foot of the upstroke and the pressure at the first peak or inflection point of the carotid pressure waveform.
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Outcomes
Major CVD events were defined as fatal or nonfatal myocardial infarction, unstable angina (prolonged ischemic episode with documented reversible ST segment changes), heart failure, and ischemic or hemorrhagic stroke. Medical records were obtained for all hospitalizations and physician visits related to CVD during follow up and were reviewed by a committee of three investigators; events were adjudicated following written guidelines. Criteria for these CVD events have been described previously. 32, 33 Follow-up evaluations were performed on data acquired through December 31, 2011.
Statistical analyses
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Major CVD ev ev even en e ts ts ts w w wer er e e e e de de efi fi fine ne n d d d as as a f f fat tal al a o o or r no no nonf nf n at at a al al al m myo yo yoca ca card rd rdia ia ial l l in i fa fa farc rc rc f f f f ti ti tion on on, , un un unst st stab ab able le le a a angina associated with increased risk for a first major CVD event adjusting for standard CVD risk factors. Baseline characteristics for the study sample were tabulated. We examined the association between separate components of hemodynamic load (FWA, global reflection coefficient, and MAP) and the time to a first major CVD event by using Cox proportional hazards regression, after confirming that the assumption of proportionality was met. Covariates were selected a priori and included components of the Framingham risk score: 34 age, sex, use of antihypertensive therapy, serum total and high density lipoprotein cholesterol concentrations, smoking, body mass index, heart rate, and presence of diabetes mellitus.
Clinically-acquired physician SBP and the components of the pressure waveform (FWA, global reflection coefficient, primary pressure wave amplitude, and MAP) were added individually to the base model. Individual hemodynamic variables that were related to the incidence of CVD events in multivariable Cox models were evaluated further after accounting for physician SBP. In addition, in order to assess whether pulsatile load, input or both related to events, characteristic impedance and peak aortic flow, which are the major correlates of FWA,
were entered together in a Cox model adjusting for covariates defined above. Similarly, in order to assess whether FWA or backward wave amplitude or both related to events, FWA and backward wave amplitude were entered together in a Cox model adjusting for covariates defined above. For individual hemodynamic variables that showed statistically significant relations with incident CVD events, we examined effect modification. We tested interactions of three covariates -older age (defined as 65 -90 vs. 40 -64), sex, and hypertension treatment statuswith hemodynamic variables by incorporating corresponding interaction terms in the analysis. In order to illustrate relations between hemodynamic variables and events, continuous predictor variables were segregated by quartiles (Q1 -Q4), and Kaplan-Meier curves of survival free of a global reflection coefficient, primary pressure wave amplitude, and MAP) were a a add dd ded ed d
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All analyses were performed with SAS version 9.3. For our primary analysis, we evaluated four components of blood pressure (FWA, reflection coefficient, primary pressure wave, and MAP); hence, a 2-sided P < 0.05/4 = 0.0125 was considered statistically significant.
Results
Study exclusion criteria resulted in a sample of 2492 participants (1402 [56%] women). Table   S1 presents a comparison of baseline characteristics of included and excluded participants.
Baseline characteristics of the study sample are presented in Table 1 . During follow-up (0.04 -6.8, median 5.4 years), 149 of 2492 participants (6%) had a first major CVD event. The most common events were myocardial infarctions (n=50), heart failure (n=46), and stroke (n=38); 13
episodes (9% of all events) were fatal. (maximum minus minimum) of these waveforms were used to define the hemodynamic components of blood pressure. Table S2 provides a correlation matrix for standard blood pressure and component hemodynamic measures.
Cox proportional hazards models for individual components of hemodynamic load are presented in Table 2 . After adjusting for standard risk factors, several of the pulsatile blood pressure measures, including physician SBP, true FWA, backward wave, and primary pressure wave amplitude, were associated with increased risk for a first major CVD event ( Table 2 , left).
In contrast, MAP and reflection coefficient were not significantly related to events in risk factor-S1 presents a comparison of baseline characteristics of included and excluded par ar rti ici ci c pa pa pant nt nts s. s.
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Discussion
Principal Findings
We investigated relations of individual mean and pulsatile components of blood pressure with incidence of first-onset CVD events in middle-age and older participants in the community-based
Framingham Heart Study. In a model that included standard CVD risk factors, SBP, primary pressure wave, and FWA were associated with increased risk whereas MAP was not, indicating that the pulsatile rather than the steady flow component of blood pressure was associated with increased risk for CVD. The global reflection coefficient was not associated with incident CVD events in the base risk factor model. Similarly, backward wave amplitude was not related to events in a dual model that included FWA, indicating that after considering the effects of FWA, relative wave reflection was not associated with CVD risk. When the base model was further adjusted for physician SBP, the association between higher FWA and CVD risk persisted, indicating that clinic SBP alone does not fully capture blood pressure-related risk. We have demonstrated previously that higher CFPWV was associated with higher CVD risk. 6 In the present study, after further adjusting for CFPWV, the relation between FWA and CVD remained, underscoring the complementary nature of these related but distinct measures of aortic function.
Additionally, in the dual model, we showed that characteristic impedance, but not peak aortic flow, was associated with elevated risk for CVD events. These data suggest that aortic wall stiffness or a mismatch between aortic diameter and pulsatile flow accounts for the increased risk associated with higher FWA. Thus, our results indicate that the forward pressure wave component of blood pressure and pulsatile load, rather than MAP, is the individual component of blood pressure that is most closely associated with first-onset major CVD events in our middleaged and older community-based sample.
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Relations of Components of Hemodynamic Load with Incident CVD Events
Several studies have evaluated relations between hemodynamic load and risk for CVD and disease-related events, [6] [7] [8] [9] [10] [11] [12] [13] Other studies that sought to assess the relation between central arterial hemodynamics and CVD events did not directly measure central aortic flow. Instead, they used either a typical flow waveform or a pseudo-flow waveform that was derived from the pressure data using various modeling assumptions. 7, 20, 21 Therefore, these studies were able to provide only an estimate of FWA and backward wave amplitude. In contrast, our study assessed the relative Ot Othe he her r r st stu ud udi ie ies s t th tha at at s sou u ugh gh ght t t to to to a ass ss ses es ss s s th th the re re rela la ati ion on b bet et etw we ween en en c c cen en ntr tr tral al ar rt rter eria ia ial l l he he h mo mo mody dy yna na ami mic c cs and CVD ev ven en nts ts ts d d did id id n n not ot t dir ir irec ec ectly y y me me meas a a ur ur ure e e ce ce ent nt ntra ra ral l ao ao a rt rt r ic ic f f flo lo low. w. w I I Ins ns nst tea a ad, d, d, t the he hey y y us us u ed ed ed e e eit it ithe he her r a typical example, in our cohort, absolute backward wave amplitude was more closely related to FWA (r=0.78, P<0.001) than to the global reflection coefficient (r=0.39, P<0.001). Additionally, pressure-only measures of wave reflection are confounded by ventricular function, which affects the balance between pressure augmentation and flow deceleration. 22, 23, 47 In the present study, to assess whether CVD event risk was attributable to increased forward or backward waves, we used a dual model that considered both FWA and backward wave amplitude: FWA remained significant while backward wave amplitude did not, demonstrating that the association between the backward pressure wave and events was attributable to larger forward wave, not greater wave reflection, which is consistent with the findings for reflection coefficient alone.
The primary pressure wave amplitude, which is a pressure-only surrogate for FWA, was not associated with CVD risk after multivariable adjustment. The primary pressure wave amplitude, which is identified by an initial peak or inflection point in the central pressure waveform (Figure 1) , may be confounded by variable overlap between forward and backward pressure waves. Depending on timing and shape of the backward wave, the true forward wave may peak before or continue to rise after the inflection point that is used to identify the transition from forward to backward pressure wave in a central pressure waveform. Therefore, primary pressure wave amplitude misclassifies a variable and informative component of the true FWA.
The current study extends prior work and implicates the FWA by demonstrating its role wave ve e, t th the e tr tr t u ue ue f f for or orwa wa war rd rd w wa av ave e f f may peak bef ef for or ore e e or or or c c con on onti t t nu nu ue e to to t r r ris is ise e af a a te te ter r th th the e e in in infl fl f ec ec ecti ti ion on o p p poi oi oint nt nt t tha ha hat t t is s s u u use se sed d d to to to i ide de ent nt ntif if fy y y th th the transition n n were not related to wave reflection or components of steady hemodynamic load as they did not provide incremental CVD risk prediction after considering standard CVD risk factors in this community-based sample of middle-aged and older people. Although risk reclassification analysis using candidate hemodynamic measures is beyond the scope of this study, we believe a thorough investigation of the relative prognostic value for individual components of hemodynamic load is an important future direction, which could improve upon current models and standard risk factors for incident CVD.
Potential Paradigm Shift in Hypertension Treatment
The World Health Organization has classified hypertension as the leading cause of preventable death throughout the world. 48 A variety of pharmacological agents approved for treatment of hypertension are widely available, included low-cost generics. Yet, control of hypertension is less than ideal, with blood pressure reduced below hypertensive levels in about half of treated patients. 3 Although current antihypertensive medications were systematically designed to reduce MAP, we have shown that MAP was not associated with CVD events in our cohort. In addition, drugs that reduce MAP, such as resistance vessel dilators, can increase cardiac output and peak flow, which could increase FWA and limit the reduction in CVD events even though SBP and MAP are reduced. These hypotheses will require testing in suitably designed intervention studies.
Recently, the Eighth Joint National Committee of the National Heart, Lung, and Blood
Institute updated the U.S. hypertension management guidelines, which set the target SBP for the population aged 60 years or older to less than 150 mm Hg. 49 The relaxed guidelines will presumably reduce the adverse effects of unnecessary antihypertensive medications. However, focusing on the level of SBP alone may incompletely characterize risk. Based on our death throughout the world. 48 A variety of pharmacological agents approved for r t t trea ea atm tm men n ent t t of of of hypertension are widely available, included low-cost generics. Yet, control of hypertension is e ess ss s t t tha ha han n id id idea ea eal, w w wit it ith h blood pressure reduced belo o ow w w h hypertensive l lev e e el ls s in in in about half of treated pati i ien e ts. 3 Altho hou u ugh h h cu cu urr ren en ent t t an an ant ti tihy hy ype pe pert rten ens sive e e m m medi i ica atio o on ns s w w wer r re e s sy ys st tem ema a ati ic cal ally ly ly d des es sig ig igne ne n d d d to to o r red ed e u u uce MA MA AP, P, P, w w we e ha ha hav ve ve s sho ho own wn n th ha hat t MA MA MAP P P wa wa was s n no not t t as as asso so s ci ci ciat at ted ed d w w wit ith h h CV CV CVD D D e ev even en ents ts t i in n ou our r r co co oho ho ort rt t. . In n n a add ddit it tio on n, d d drugs that red ed duc uc uce e MA MA M P, P, P, suc uc uch h h as s s r r res es e is is ista a anc nc nce e e ve ve vess ss ssel el l di di d la la lato tors rs rs, , ca ca can n n in in incr c ea ea ease se se c c car ar ardi di d ac ac c o o out ut utpu pu put t and peak observations, we posit that a borderline-to-high SBP with normal FWA may not be as risky as a comparable SBP with markedly elevated FWA. Such a distinction may make it possible to ease the guidelines for SBP while still identifying cases that will benefit from more aggressive treatment.
Furthermore, our data suggest a need to better define the effects of existing therapeutic agents on aortic function and FWA. For example, a prior study used a hemodynamic protocol analogous to the one used in the present study and demonstrated that relatively short-term therapy with omapatrilat reduced PP, characteristic impedance, and FWA in middle-aged and older patients with uncomplicated systolic hypertension. 50 Similar evaluation of novel and existing therapies would better define the hemodynamic effects of antihypertensive drug therapy and would inform design of clinical trials that could test the potential clinical value of a treatment strategy that targets modification of proximal aortic properties as a primary goal of therapy. Whether current or novel drugs with favorable effects on proximal aortic properties that produce preferential reduction in FWA will be more effective at reducing CVD events will require prospective evaluation in randomized trials.
Limitations
Our study has limitations that should be considered. Our prospective study is observational; therefore, we are unable to demonstrate a causal link underlying the association between increased FWA and increased CVD events. In addition, we cannot discount the possibility of residual confounding by duration or severity of unknown or associated risk factors. Although we adjusted for use of antihypertensive medications and did not find evidence of effect modification by their usage, this potential confounder was highly prevalent in our cohort (45%). Furthermore, during the follow-up period, the cohort had a modest number of events; however, we had existing therapies would better define the hemodynamic effects of antihypertens siv iv ve e dr drug ug ug t t the he hera rapy py and would inform design of clinical trials that could test the potential clinical value of a r rea ea atm tm tme en ent t t st st stra ra ategy gy gy t tha h t targets modification of pr r rox ox o i imal aortic prop op operti tie e es s s as a a primary goal of h h her r rap a y. Wheth th he er r c c cur urr re rent nt nt o o or r r no no nove vel l l d dr dru ug gs s wit th th favo or ora able le e e eff ff fe ec ects ts o o on pr rox ox xim m mal al a ao ort rtic ic c p pro ro r p p pert rt rti ie ies s s th th hat pr prod od oduc uc uce e pr pr pref ef efer eren en nti ial al r red educ uc u ti t on on on i i in n n FW FW FWA A A wi wi will ll ll be e e mo mo or re e e e eff ff fec ec ecti ti tive ve e a at t re e edu du duc ci ing ng g C C CVD VD VD e eve ve ven nts s s w wi will ll equire prospe pe pect ct ctiv iv ve e e ev ev eval al lua uati ti tion on on i i in n n ra ra rand nd n om om omiz iz ized ed ed t tri ri r al al a s. s. s adequate power to detect moderate effects. In addition, since the low number of incident CVD events reduces the precision of the estimates, an estimation of risk reclassification was not performed. Finally, since we evaluated participants who were middle-aged and older and predominately white, our results may not be generalizable to younger individuals or different ethnicities.
Conclusion
In summary, we have shown that FWA is the key component of hemodynamic load that is associated with CVD events in a model that adjusts for standard risk factors. Current pharmacological strategies used to treat hypertension focus on reducing hemodynamic load by reducing MAP and may not adequately address a primary cause of blood pressure elevation, 10 CVD progression, and associated excess morbidity and mortality. Our data suggest that further research on hemodynamic mechanisms and clinical effects of interventions that focus on proximal aortic properties and pulsatile load is merited. 
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